| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778567 | European Urology | 2018 | 4 Pages |
Abstract
In this report, we studied the effect of chemotherapy in metastatic bladder cancer, which relapsed after immune checkpoint inhibitors. We found that the activity of chemotherapy was maintained despite previous exposure to immune therapy. This underlines the importance of sequencing these agents to maximise outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Bernadett Szabados, Nick van Dijk, Yen Zhi Tang, Michiel S. van der Heijden, Akhila Wimalasingham, Alfonso Gomez de Liano, Simon Chowdhury, Simon Hughes, Sarah Rudman, Mark Linch, Thomas Powles,